BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2025 9:39:08 AM | Browse: 39 | Download: 64
 |
Received |
|
2025-06-16 02:36 |
|
Peer-Review Started |
|
2025-06-16 02:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-06-19 06:26 |
|
Revised |
|
2025-06-30 09:34 |
|
Second Decision |
|
2025-08-05 02:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-08-05 12:10 |
|
Articles in Press |
|
2025-08-05 12:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-18 07:24 |
|
Publish the Manuscript Online |
|
2025-08-28 09:39 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Heterogeneous outcomes in metabolic dysfunction–associated steatotic liver disease/steatohepatitis with type 2 diabetes: Rethinking risk and management approaches
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ze-Xu Zheng and Shu-Min Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shu-Min Huang, MD, . 410292712@qq.com |
| Key Words |
Metabolic dysfunction–associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Type 2 diabetes; Hepatocellular carcinoma; Ethnic disparities |
| Core Tip |
The authors not only delineate, with granular precision, the clinical trajectories of Hispanic and non-Hispanic patients across the United States and the Gulf Coast of Texas, but also furnish a rigorous quantification of metabolic dysfunction–associated steatotic liver disease/steatohepatitis (MASLD/MASH) -related event rates. Their synthesis provides an invaluable scaffold for early risk stratification and the refinement of therapeutic and surveillance algorithms. This work underscores the imperative of nuanced appraisal of MASLD/MASH outcomes and bespoke management strategies, interrogating regional heterogeneity in disease burden, the merits of integrated metabolic care, and the potential of lifestyle modification to mitigate complications and enhance prognosis. |
| Publish Date |
2025-08-28 09:39 |
| Citation |
<p>Zheng ZX, Huang SM. Heterogeneous outcomes in metabolic dysfunction–associated steatotic liver disease/steatohepatitis with type 2 diabetes: Rethinking risk and management approaches. <i>World J Clin Cases</i> 2025; 13(29): 110771</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i29/110771.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i29.110771 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
